Lenzen M, Malik A, Li M, Fry J, Weisz H, Pichler PP, et al. The environmental footprint of health care: a global assessment. Lancet Planet Health. 2020;4:e271–e279.

Article  PubMed  Google Scholar 

NHS England. Delivering a Net Zero National Health Service, https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf (2022).

NHS Digital. Hospital Outpatient Activity 2019-20. NHS Digital, https://digital.nhs.uk/data-and-information/publications/statistical/hospital-outpatient-activity/2019-20/summary-report---treatment-specialities (2020, accessed 27 May 2021).

Buchan JC, Thiel CL, Steyn A, Somner J, Venkatesh R, Burton MJ, et al. Addressing the environmental sustainability of eye health-care delivery: a scoping review. Lancet Planet Health. 2022;6:e524–e534.

Article  PubMed  Google Scholar 

Wong YL, Noor M, James KL, Aslam TM. Ophthalmology going greener: a narrative review. Ophthalmol Ther. 2021;10:845–57.

Article  PubMed  PubMed Central  Google Scholar 

Rossi T, Romano MR, Iannetta D, Romano V, Gualdi L, D'Agostino I, et al. Cataract surgery practice patterns worldwide: a survey. BMJ Open Ophthalmol. 2021;6:e000464.

Article  PubMed  PubMed Central  Google Scholar 

Chopra R, Preston GC, Keenan TDL, Mulholland P, Patel PJ, Balaskas K, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye (Lond). 2022;36:1373–8.

Article  PubMed  Google Scholar 

Hollingworth W, Jones T, Reeves BC, Peto T. A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015. BMJ Open. 2017;7:e018289.

Article  PubMed  PubMed Central  Google Scholar 

Vision profile statistical commentary: September 2023. GOV.UK, https://www.gov.uk/government/statistics/vision-profile-september-2023/vision-profile-statistical-commentary-september-2023 (accessed 24 September 2023).

Power B, Brady R, Connell P. Analyzing the Carbon Footprint of an Intravitreal Injection. J Ophthalmic Vis Res. 2021;16:367–76.

PubMed  PubMed Central  Google Scholar 

Cantanese L Second Geographic Atrophy Treatment Receives FDA Approval | BrightFocus Foundation, https://www.brightfocus.org/macular/news/second-geographic-atrophy-treatment-receives-fda-approval (accessed 30 September 2023).

Research News. FDA Approves First and Only Treatment for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration | BrightFocus Foundation, https://www.brightfocus.org/news/fda-approves-first-and-only-treatment-geographic-atrophy-advanced-form-age-related-macular (accessed 30 September 2023).

Tennison I, Roschnik S, Ashby B, Boyd R, Hamilton I, Oreszczyn T, et al. Health care’s response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5:e84–e92.

Article  PubMed  PubMed Central  Google Scholar 

Psillaki M, Apostolopoulos N, Makris I, Liargovas P, Apostolopoulos S, Dimitrakopoulos P, et al. Hospitals’ energy efficiency in the perspective of saving resources and providing quality services through technological options: a systematic literature review. Energies. 2023;16:755.

Article  Google Scholar 

Greener NHS» Solar power sparks an electrical future for Milton Keynes University Hospital, https://www.england.nhs.uk/greenernhs/whats-already-happening/solar-power-sparks-an-electrical-future-for-milton-keynes-university-hospital/ (accessed 13 March 2024).

Sundar D, Das T, Chhablani J, Kumar A, Sharma N. All India Ophthalmological Society members’ survey: practice pattern of intravitreal anti-vascular endothelial growth factor injection. Indian J Ophthalmol. 2020;68:1095–8.

Article  PubMed  PubMed Central  Google Scholar 

Rizan C, Steinbach I, Nicholson R, Lillywhite R, Reed M, Bhutta MF. The carbon footprint of surgical operations: a systematic review. Ann Surg. 2020;272:986–95.

Article  PubMed  Google Scholar 

MacNeill AJ, Lillywhite R, Brown CJ. The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems. Lancet Planet Health. 2017;1:e381–e388.

Article  PubMed  Google Scholar 

Javitt MJ, Grossman A, Grajewski A, Javitt JC. Association between eliminating water from surgical hand antisepsis at a large ophthalmic surgical hospital and cost. JAMA Ophthalmol. 2020;138:382–6.

Article  PubMed  PubMed Central  Google Scholar 

Chandra P, Welch S, Oliver GF, Gale J. The carbon footprint of intravitreal injections. Clin Exp Ophthalmol. 2022;50:347–9.

Article  PubMed  Google Scholar 

Elrod JK, Fortenberry JL. The hub-and-spoke organization design: an avenue for serving patients well. BMC Health Serv Res. 2017;17:457.

Article  PubMed  PubMed Central  Google Scholar 

Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, et al. Endophthalmitis rates after bilateral same-day intravitreal anti–vascular endothelial growth factor injections. Am J Ophthalmol. 2018;194:1–6.

Article  CAS  PubMed  Google Scholar 

Emerson GG, Thompson JT, Vo LV, Mason R, Lee GD, Leder HA. Office examinations–directed treatment paradigms reduce travel burden, decrease treatment cost, and improve quality-adjusted life-years for patients with exudative age-related macular degeneration undergoing antivascular endothelial growth factor therapy. J Vitreoretina Dis. 2020;4:472–8.

Article  Google Scholar 

Khanani AM, Patel SS, Ferrone PJ, Osborne A, Sahni J, Grzeschik S, et al. Efficacy of every four monthly and quarterly dosing of faricimab vs ranibizumab in neovascular age-related macular degeneration: the STAIRWAY phase 2 randomized clinical trial. JAMA Ophthalmol. 2020;138:964–72.

Article  PubMed  PubMed Central  Google Scholar 

Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, et al. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022;399:741–55.

Article  CAS  PubMed  Google Scholar 

Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, et al. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024;403:1153–63.

Article  CAS  PubMed  Google Scholar 

Lanzetta P, Korobelnik J-F, Heier JS, Leal S, Holz FG, Clark WL, et al. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial. Lancet. 2024;403:1141–52.

Article  CAS  PubMed  Google Scholar 

Ranade SV, Wieland MR, Tam T, Rea JC, Horvath J, Hieb AR, et al. The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery. Drug Deliv;. 2022;29:1326–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma A, Khanani AM, Parachuri N, Kumar N, Bandello F, Kuppermann BD. Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists. Int J Retin Vitr. 2023;9:6.

Article  Google Scholar 

Bjerager J, Schneider M, Potapenko I, van Dijk E, Faber C, Grauslund J, et al. Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. JAMA Ophthalmol. 2023;141:315–23.

Article  PubMed  Google Scholar 

Busquets MA, Sabbagh O. Current status of home monitoring technology for age-related macular degeneration. Curr Opin Ophthalmol. 2021;32:240–6.

Article  PubMed  Google Scholar 

Balaskas K, Drawnel F, Khanani AM, Knox PC, Mavromaras G, Wang YZ. Home vision monitoring in patients with maculopathy: current and future options for digital technologies. Eye (Lond). 2023;37:1–13.

Miller JRC, Patel PJ, Hanumunthadu D. Perspectives on the home monitoring of macular disease. Ophthalmol Ther. 2023;12:1–6.

Article  CAS  PubMed  Google Scholar 

Birtel J, Heimann H, Hoerauf H, Helbig H, Schulz C, Holz FG, et al. Sustainability in ophthalmology: Adaptation to the climate crisis and mitigation. Ophthalmologie. 2022;119:567–76.

Article  PubMed  PubMed Central  Google Scholar 

Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augenärzte Deutschlands e. V. (BVA) [Position paper and recommendations for action for ecologically sustainable ophthalmology: Statement of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. Ophthalmologie. 2023;120:52–68.

Google Scholar 

Birtel J, Hammer M, Feltgen N, et al. Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste. Klin Monbl Augenheilkd. Epub ahead of print 4 April 2024. https://doi.org/10.1055/a-2184-9492.

van Leeuwen R, Elferink S Ophthalmology and the climate crisis: Time to take responsibility. Ophthalmology Times Europe; 18.

Gale J, Welch SH, Niederer R. Intravitreal injections with a low consumption technique have a low infection rate. Eye (Lond). 2023;38:1–2.

Cameron TW, Vo LV, Emerson LK, Emerson MV, Emerson GG. Medical waste due to intravitreal injection procedures in a retina clinic. J Vitreoretin Dis. 2021;5:193–8.

Article  PubMed  PubMed Central